c-Src inhibitors displayed potent anticancer activity.
The bioactivities of 80 pyrrolo-pyrimidines inhibitors were investigated.
QSAR were constructed with constitutional, topological and flexible descriptors.
The models were validated using the recommended by OECD guidelines.
The statistical results are satisfactory and in line with published 3D-QSAR.